Population-based FMR1 carrier screening among reproductive women

dc.contributor.authorQuratul Ain
dc.contributor.authorYe Hyun Hwang
dc.contributor.authorD. K.‐W. Yeung
dc.contributor.authorPacharee Panpaprai
dc.contributor.authorWiwat Iamurairat
dc.contributor.authorWiboon Chutimongkonkul
dc.contributor.authorObjoon Trachoo
dc.contributor.authorFlora Tassone
dc.contributor.authorPoonnada Jiraanont
dc.date.accessioned2026-05-08T19:18:09Z
dc.date.issued2024-9-25
dc.description.abstractPURPOSE: Fragile X syndrome (FXS) is a neurodevelopmental disorder, caused by an CGG repeat expansion (FM, > 200 CGG) in the fragile X messenger ribonucleoprotein 1 (FMR1) gene. Female carriers of a premutation (PM; 55-200 CGG) can transmit the PM allele, which, depending on the CGG allele size, can expand to an allele in the FM range in the offspring. METHODS: Carrier screening for FMR1 PM is not available in Thailand. This study aimed to investigate the prevalence of PM carriers among Thai reproductive women at the tertiary hospital. A total of 1250 females participated in this study; ages ranged from 20 to 45 years, mean of 30 years (S.D. = 6.27). RESULTS: Two carriers of a premutation allele, with 32,62 and 32,69 CGG repeats respectively, were identified. This corresponds to 1 in 600 women or 0.17% of the population. Further, three women carrying a gray zone allele (45-54 CGG repeats) were identified (29,51; 29,49; and 30,47 CGG repeats) which equals to 1:400 women or 0.25% of the population. No FM case was detected. CONCLUSIONS: This study heightens the importance of PM carrier screening of women of reproductive age, particularly for the higher risk of developing fragile X-associated primary ovarian insufficiency (FXPOI). Early identification of PM carrier status enhances family planning and fecundity alternatives and improves reproductive health outcomes leading to a better life.
dc.identifier.doi10.1007/s10815-024-03242-2
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/16391
dc.publisherJournal of Assisted Reproduction and Genetics
dc.subjectGenetics and Neurodevelopmental Disorders
dc.subjectUbiquitin and proteasome pathways
dc.subjectAutism Spectrum Disorder Research
dc.titlePopulation-based FMR1 carrier screening among reproductive women
dc.typeArticle

Files

Collections